2020 Efficacy Testing Market Report- Application: Pharmaceutical Manufacturing, Cosmetic & Personal Care Products, Consumer

The global efficacy testing market is projected to reach USD 333 million by 2025 from USD 261 million in 2020, at a CAGR of 5.0% during the forecast period. 

ReportsnReports added Efficacy Testing Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Efficacy Testing Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Efficacy Testing Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1308638

Top Company Profile Analysis in this Report- Charles River Laboratories (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek Group (UK), Nelson Laboratories, LLC (a Sotera Health company, US), Microbac Laboratories, Inc. (US), Almac Group (UK), North American Science Associates, Inc. (US), Toxikon (US), Pacific Biolabs (US), MSL Solution Providers (UK), Intertek Group PLC (UK), Accugen Laboratories, Inc. (US), Consumer Product Testing Company (US), Lucideon (UK), BioScience Laboratories, Inc. (US), ALS Limited (Australia), Microchem Laboratory (US), Oxford Biosciences Ltd. (UK), Abbott Analytical (Australia), Helvic Laboratories (a Tentamus Company, UK), Honeyman Group Limited (UK), Danish Technological Institute (DTI, Denmark), and BluTest Laboratories Limited (UK).

The report segments the efficacy testing market  based on region (Asia Pacific, Europe, North America, and RoW), service type (disinfectant efficacy testing and antimicrobial/preservative efficacy testing), application (pharmaceutical manufacturing applications, cosmetics and personal care product applications, consumer product applications, and medical device applications).

The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability; growing preference for outsourcing efficacy testing; and the rising adoption of the QbD approach

In the traditional test method, a sample of the pharmaceutical or cosmetic product is inoculated with a microbial suspension of a population of a regulatory recognized key microorganism. This is followed by sampling and the determination of the number of colony-forming units (CFU) and the microbial survival rate with the help of aerobic plate count, surface spread, or membrane filtration techniques after a suitable incubation time. As these test methods are in accordance with the guidelines and standards set by regulatory authorities, they are widely used by service providers

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the fast-growing pharmaceutical industry in this region, favorable government policies, and the increasing number of pharmaceutical companies establishing manufacturing facilities in APAC countries.

North America accounted for the largest share of the efficacy testing market. Factors such as the presence of a wellestablished pharmaceutical industry in the region, the high R&D expenditure, a strong presence of major service providers, and rising outsourcing of analytical testing (including efficacy testing) by pharmaceutical and cosmetic companies in the region are the major factors driving the market growth.

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

By Respondent– Supply Side- 80%, Demand Side-20%
By Designation— Executives- 25%, CXOs- 20%, Managers - 55%
By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%

Single User License: US $ 4950 
Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=1308638

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the efficacy testing market and provides them information on key market drivers, challenges, and opportunities.

Table Of Contents in this Report-
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary Of Changes

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Data
2.1.2 Primary Data
2.1.2.1 Breakdown Of Primary Sources
Figure 1 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
Figure 2 Market Size Estimation: Supply-Side Analysis
Figure 3 Efficacy Testing Market: Final Cagr Projections (2020−2025)
Figure 4 Efficacy Testing Market: Cagr Projections From The Analysis Of Demand-Side Drivers, Challenges, And Opportunities
Figure 5 Efficacy Testing Market: Segmental Assessment
2.3 Market Breakdown And Data Triangulation
Figure 6 Data Triangulation Methodology
2.4 Market Ranking Analysis
2.5 Research Assumptions

3 Executive Summary
Figure 7 Efficacy Testing Market, By Service Type, 2020 Vs. 2025 (Usd Million)
Figure 8 Efficacy Testing Market, By Application, 2020–2025
Figure 9 Geographical Snapshot Of The Efficacy Testing Market

4 Premium Insights
4.1 Efficacy Testing Market Overview
Figure 10 Growing Preference For Outsourcing Efficacy Testing To Drive Market Growth
4.2 Asia Pacific: Efficacy Testing Market, By Application & Country (2019)
Figure 11 Pharmaceutical Manufacturing Applications Segment Accounted For The Largest Share Of The Asia Pacific Market In 2019
4.3 Disinfectant Efficacy Testing Market, By Method
Figure 12 Surface Test Method Segment To Witness The Highest Growth During The Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 13 Efficacy Testing Market: Drivers, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Increasing Use Of Surface Disinfectants And Preservatives In Pharma, Biopharma, And Cosmetics Industries For Contamination Control And Product Stability
5.2.1.1.1 Rising Focus On Contamination Control
5.2.1.1.2 Increasing Concerns Over Product Stability
5.2.1.2 Growing Preference For Outsourcing Efficacy Testing
5.2.1.3 Rising Adoption Of The Quality By Design Approach
5.2.2 Opportunities
5.2.2.1 Emerging Countries In The Asia Pacific Region
5.2.3 Challenges
5.2.3.1 Time-Consuming Process
5.3 Regulatory Analysis
5.3.1 Disinfectant Efficacy Testing
5.3.2 Antimicrobial Efficacy Testing
5.4 Impact Of Covid-19 On Efficacy Testing Services

and more...

 

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.